| Title : Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease - Fontana_1998_Br.J.Clin.Pharmacol_46_221 |
| Author(s) : Fontana RJ , deVries TM , Woolf TF , Knapp MJ , Brown AS , Kaminsky LS , Tang BK , Foster NL , Brown RR , Watkins PB |
| Ref : British Journal of Clinical Pharmacology , 46 :221 , 1998 |
| Abstract : |
| PubMedSearch : Fontana_1998_Br.J.Clin.Pharmacol_46_221 |
| PubMedID: 9764962 |
| Title : The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity - Fontana_1996_Hepatology_23_1429 |
| Author(s) : Fontana RJ , Turgeon DK , Woolf TF , Knapp MJ , Foster NL , Watkins PB |
| Ref : Hepatology , 23 :1429 , 1996 |
| Abstract : |
| PubMedSearch : Fontana_1996_Hepatology_23_1429 |
| PubMedID: 8675160 |
| Title : Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease - Watkins_1994_JAMA_271_992 |
| Author(s) : Watkins PB , Zimmerman HJ , Knapp MJ , Gracon SI , Lewis KW |
| Ref : Jama , 271 :992 , 1994 |
| Abstract : |
| PubMedSearch : Watkins_1994_JAMA_271_992 |
| PubMedID: 8139084 |